Categories: News

Danaher Cryogenics Acquires ADR Cryostat Product Line from High Precision Devices, a Subsidiary of FormFactor, Complementing Existing Sub-Kelvin Offerings

BOULDER, Colo. , Jan. 7, 2025 /PRNewswire/ — Danaher Cryogenics, a leader in manufacturing of fully-integrated, sub-Kelvin cryostats and engineering elegant cryogenic solutions, today announced the acquisition of the Adiabatic Demagnetization Refrigerator (ADR) Cryogenic product line from Boulder-based High Precision Devices, Inc. (HPD), a subsidiary of FormFactor.

Danaher Cryogenic’s acquisition of HPD’s ADR Cryogenics product line follows over 20 years of HPD’s leading presence in the ADR cryogenic space. HPD’s ADR cryostats have been deployed as the cryogenic workhorse to many world-class institutions, including NIST, NASA, INRiM, and national laboratories such as Argonne National Laboratory, Fermilab, Los Alamos National Laboratory, and Brookhaven National Laboratory, among many others.

“Danaher Cryogenics is proud to continue in the legacy of HPD, providing scientists and researchers with excellent cryogenic solutions that help advance astronomy, Quantum Computing, and many other critical fields,” said Charlie Danaher, President and Founder of Danaher Cryogenics. “We look forward to working with the scientists and researchers who use these versatile tools to perform exciting and important work.”

ADR cryostats will serve as a strategic addition to Danaher Cryogenics’ existing cryogenic product line-up, consisting of a family of sub-Kelvin cryostats that incorporate Chase Research Cryogenics sorption coolers and Leiden Cryogenics Dilution Refrigerators.

ADR cryostats offer users a convenient way to perform experiments at temperatures below 100 mK. This temperature range is useful for various fields, including astronomy, Quantum Computing, Material Research, and Condensed Matter Physics. A unique characteristic of ADR cryostats is their insensitivity to gravity. Where nearly all other sub-Kelvin coolers are sensitive to – and dependent upon – gravity, ADRs can operate effectively in any orientation.

Whereas Danaher Cryo’s Chase-based sub-Kelvin cryostats offer base temperatures in the range from 1 K down to 100 mK, and the Leiden Cryogenics Dilution Refrigerators offer ultralow temperatures near 10 mK, the addition of the ADRs – operating between 100 mK and 30 mK – fills this gap and allows Danaher Cryogenics to offer products covering the full sub-Kelvin temperature spectrum.

Charlie Danaher said, “By now covering the entire range of sub-Kelvin temperatures, Danaher Cryogenics is uniquely positioned for the next frontier in cryogenics.”

About Danaher Cryogenics

Danaher Cryogenics pursues the near impossible with elegant, classic solutions to manifest optimal cryogenic performance from initial concept to fruition. Reach us at www.danahercryo.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/danaher-cryogenics-acquires-adr-cryostat-product-line-from-high-precision-devices-a-subsidiary-of-formfactor-complementing-existing-sub-kelvin-offerings-302344488.html

SOURCE Danaher Cryo

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

20 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

20 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

20 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

20 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

20 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

20 hours ago